Search

You searched for "ophthalmic disease"

971 results found

The ‘art’ of refraction – designing a refraction course

1 April 2016 | | EYE - Cataract, EYE - Refractive
Learning how to refract requires theoretical knowledge, practice and determination. Refraction is a notoriously challenging skill to acquire and the competing demands on junior ophthalmologists can often be restrictive of the development of this core skill. To consolidate theory learnt...

The increasing privatisation of ophthalmology: How has and how will it affect resident doctors?

20 August 2025 | | EYE - Cataract
It’s well known that the rising number of private ophthalmology providers in the UK have continued to increase their market share in providing various services. Referrals from NHS trusts have continued to increase with nearly 60% of cataract operations being...

Pituitary tumours: why are they so often missed?

1 April 2017 | | EYE - Neuro-ophthalmology
Part 1: Introduction, historical background and Edinburgh connections (see also Part 2 and Part 3) Is there any ophthalmologist who has not missed a pituitary tumour? Hopefully this article will help those currently in practice to avoid such an embarrassment,...

Advances in cataract surgery

1 April 2018 | | EYE - Cataract, EYE - Refractive
This article covers recent clinical findings in mydriasis and anaesthesia for cataract surgery, shared by Sathish Srinivasan and Keith Davey at a surgical meeting in Manchester. Towards dropless cataract surgery Day case cataract surgery is the standard of care in...

Ophthalmology in the developing world

1 April 2014 | | EYE - General
After the second year of medical school, I spent my summer vacation working as a volunteer for a small Italian non-government organisation (NGO), named HEALTH-AID. As part of my volunteering experience, I joined a team of European doctors, medical students...

Twenty-five years in retina

1 February 2019 | | EYE - Vitreo-Retinal, EYE - General
In the next of our articles celebrating 25 years of Eye News, the authors look at how the retina specialty has changed over this time and ask what the future might hold. Retinal disease management has benefited from great advances...

Harry Moss Traquair: Edinburgh Ophthalmologist and Father Figure of Perimetry

3 February 2023 | | EYE - General
It is a unique honour bestowed upon only a few clinicians, that their name becomes for evermore associated with the subject of their particular expertise and knowledge. Such an individual is undoubtedly Harry Moss Traquair, an Edinburgh-based ophthalmologist, who in...

The New Zealand National Eye Centre and the land of the long white cloud

4 October 2023 | | EYE - General
Located southeast of Australia in the South Pacific Ocean, New Zealand (Aotearoa) is home to five million culturally diverse people. Renowned for its lush nature spanning from unexplored forests to active volcanos and snow-capped mountains, New Zealand has become both...

The miracle of multi-professional working in modern-day eyecare

6 April 2021 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
"It’s a Tuesday morning, and I’m in the presence of one of the most mind-boggling accomplishments in human history. This thing is so astounding in its complexity and scope, it makes the Panama Canal look like a third grader’s craft...

Sustainability in ophthalmology and healthcare: An overview

2 April 2025 | | EYE - General
Finally, even staunch sceptics are coming around to recognising that climate change is real and that we should do something about it. But how proximal the threat is and at what pace change has to happen is not universally agreed...

Semaglutide and vision loss: A new concern for NAION risk?

4 December 2025 | | EYE - Neuro-ophthalmology
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as transformative agents in...

Outcomes at 100 weeks from the LEAVO study of intravitreal anti-VEGF therapies for macular oedema secondary to central retinal vein occlusion

23 May 2019 |
Royal College of Ophthalmologists Annual Congress 2019, Glasgow - First presented and discussed on Monday 20 May 2019, with a further presentation of results during Retina Subspecialty Day on Thursday 23 May 2019. Among patients with macular oedema secondary to...